Navigation Links
2008 Human Research Protection Award Recipients Announced
Date:12/29/2008

BETHESDA, Md., Dec. 29 /PRNewswire-USNewswire/ -- The winner of the 2008 Award for Excellence in Human Research Protection was announced today by Dr. Peter G. Goldschmidt, President and Founder of the Health Improvement Institute.

The winner of the annual award was the University of Texas M.D. Anderson Cancer Center -- for its best practice "IND Regulatory and Monitoring Program." This program provides for 1) enhanced human subjects protection, 2) improved data quality for clinical trials, 3) an active, vital relationship with federal agencies and 4) increased protection for institutions.

"The Award program offers a way to gain positive recognition for excellence in the field of human research protection," said Dr. Goldschmidt. "This year's winner continues the high standard in best practices that have been submitted for an Award since the program began."

Awards are given for demonstrated excellence in promoting the well being of people who participate in research. The Health Improvement Institute created this Award program. The Office of Human Research Protection was the founding sponsor of the Award program. Judges and Committee and Award Advisory Board members are volunteers. This year's judges were drawn from provider, research review, compliance, legal, and consulting organizations.

About Health Improvement Institute:

Health Improvement Institute is a non-profit, tax exempt, 501(c)3, charitable organization dedicated to improving the quality and productivity of America's health care. The Institute's principal program objective it to provide information to enable people to make informed health care choices. The Institute has established expertise in evaluating the quality of health information on the Internet, conducts forms and workshops, and sponsors national awards programs to recognize excellence, including the Award for Excellence in Human Research Protection. For more information, visit www.hii.org.

The Office for Human Research Protections (OHRP) -- together with the federal Food and Drug Administration -- oversees programs for the protections of human subjects at more than 4,000 HHS-funded universities, hospitals, and other medical and behavioral research institutions and private research sites in the United States and abroad.

For information about the 2009 Award for Excellence in Human Research Protection, please contact the Award Coordinator at 301-320-0965 or by email at hii@hii.org.


'/>"/>
SOURCE Health Improvement Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):